Hydralazine and furosemide kinetics
- 31 August 1982
- journal article
- research article
- Published by Springer Nature in Clinical Pharmacology & Therapeutics
- Vol. 32 (3) , 303-306
- https://doi.org/10.1038/clpt.1982.164
Abstract
Furosemide kinetics were studied in 25 patients with congestive heart failure. The elimination half-life (t 1/2) was longer and the elimination rate constant and the plasma clearance smaller in patients with advanced (n = 15) than in those with moderate (n = 10) failure. Furosemide kinetics with and without hydralazine were compared in 8 patients with advanced heart failure. Furosemide t 1/2 in patients receiving both drugs fell from 96 .+-. 16 to 81 .+-. 15 min (P < 0.02), elimination rate constant increased from 0.0186 .+-. 0.0056 to 0.0214 .+-. 0.0068 min-1 (P < 0.05), and plasma clearance rose from 72.6 .+-. 18.5 to 88.1 .+-. 26.9 ml/min (P < 0.01). Renal clearance rose from 45.4 .+-. 12.0 to 60.9 .+-. 19.0 ml/min (P < 0.01) and creatinine clearance was unchanged. Apparently, hydralazine affects furosemide kinetics.This publication has 4 references indexed in Scilit:
- Reduction of Liver Blood Flow and Propranolol Metabolism by CimetidineNew England Journal of Medicine, 1981
- Distribution, elimination and effect of furosemide in normal subjects and in patients with heart failureEuropean Journal of Clinical Pharmacology, 1977
- Binding of Drugs to Serum AlbuminNew England Journal of Medicine, 1976
- Lidocaine Pharmacokinetics in Advanced Heart Failure, Liver Disease, and Renal Failure in HumansAnnals of Internal Medicine, 1973